NaviFUS

NaviFUS Equity

The The Equity of NaviFUS (6872.TWO) as of Oct 18, 2026 is 555.65 M TWD. In the previous year, The Equity was 481.50 M TWD — a change of 15.40% (higher).

Equity

555.65 MTWD

YoY

15.40%

Last updated:

In 2025, NaviFUS's equity was 555.65 M TWD, a 15.40% increase from the 481.50 M TWD equity in the previous year.

The NaviFUS Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
237.92 M TWD
Jan 1, 2020
327.17 M TWD
Jan 1, 2021
546.44 M TWD
Jan 1, 2022
484.95 M TWD
Jan 1, 2023
423.00 M TWD
Jan 1, 2024
481.50 M TWD
Jan 1, 2025
555.65 M TWD
The NaviFUS Equity history
YEAREquityYoY
555.65 MTWD+15.40%
481.50 MTWD+13.83%
423.00 MTWD-12.77%
484.95 MTWD-11.25%
546.44 MTWD+67.02%
327.17 MTWD+37.51%
237.92 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NaviFUS Stock analysis

What does NaviFUS do? NaviFUS Corp, listed on the Taiwan Stock Exchange under ticker 6872.TWO with ISIN TW0006872005, is a health care company headquartered in Taipei City, Taiwan. The company went public on June 22, 2022. NaviFUS Corp operates as a medical device company specializing in the development of two core technology platforms: focused ultrasound systems and therapeutic guidance tracking systems. The firm's focus includes the development of medical systems targeting recurrent brain tumors and Alzheimer's disease. The company's website is https://navifus.com/. NaviFUS Corp is engaged in the health care sector, specifically within the health care industry. The company's operations are centered on advancing medical technologies for neurological conditions, with an emphasis on non-invasive treatment approaches. While the company's specific products and market presence are not detailed in the provided information, its technological focus suggests a commitment to innovative solutions in neurology and neurosurgery. The firm's public listing in 2022 marks its transition into a publicly traded entity, reflecting its growth and development in the medical device sector. NaviFUS Corp's headquarters in Taipei City positions it within Taiwan's growing health care technology landscape, contributing to regional advancements in medical innovation. NaviFUS is one of the most popular companies on Eulerpool.

Equity Details

Analyzing NaviFUS's Equity

NaviFUS's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding NaviFUS's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating NaviFUS's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

NaviFUS's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in NaviFUS’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about NaviFUS stock

The Equity of NaviFUS is 555.65 M TWD in 2025.

The Equity of NaviFUS changed from 481.50 M TWD to 555.65 M TWD, representing a 15.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity NaviFUS since 2006 – with annual values, charts, and detailed analysis.

The Equity's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's NaviFUS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — NaviFUS

All Key Metrics — NaviFUS